BOUCHERVILLE, QC, Nov. 20, 2025 /CNW/ - LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma"), a Canadian integrated pharmaceutical company, today reported its fourth consecutive record quarterly revenues and financial results for the third quarter of its 2025 fiscal year, ended September 30, 2025 ("Q3 2025" and "Year-to-date 2025"). All amounts are presented in thousands of Canadian dollars.
Read more at newswire.caLSL PHARMA GROUP REPORTS FOURTH CONSECUTIVE RECORD QUARTERLY REVENUES AND Q3 2025 FINANCIAL RESULTS
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.